Quarterly report pursuant to Section 13 or 15(d)

Supplemental Equity and Accumulated Other Comprehensive Income (Loss) - Consolidated Changes in Equity (Details)

v3.24.0.1
Supplemental Equity and Accumulated Other Comprehensive Income (Loss) - Consolidated Changes in Equity (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Dec. 31, 2023
Sep. 30, 2023
Dec. 31, 2022
Sep. 30, 2022
Dec. 31, 2023
Dec. 31, 2022
Balances $ 1,997,746 $ 1,966,516 $ 1,751,154 $ 1,701,011 $ 1,966,516 $ 1,701,011
Balances (in shares)   157,641,914     157,641,914  
Net earnings 27,465 $ 50,993 50,005 89,734 $ 78,459 139,739
Other comprehensive income (loss) 14,355 (11,952) 16,685 (16,762)    
Reclassification of cumulative translation adjustment for Eminence to non-operating income       119   $ 119
Elimination of noncontrolling equity interest from sale of Eminence       613    
Share repurchases (80,042)     (19,562)    
Common stock issued for exercise of options 3,841 (2,577) 5,075 (2,005)    
Common stock issued for exercise of options (in shares)         1,218,443 814,807
Common stock issued for restricted stock awards 0 (4,767) 2 (6,427)    
Cash dividends (12,559) (12,654) (12,561) (12,545)    
Stock-based compensation expense 12,413 9,981 16,413 14,364    
Common stock issued to employee stock purchase plan   2,094   2,517    
Employee stock purchase plan expense 340 112 333 97    
Balances $ 1,963,559 1,997,746 1,827,106 1,751,154 $ 1,963,559 $ 1,827,106
Balances (in shares) 157,142,004       157,142,004  
Common Stock            
Balances $ 1,584 $ 1,576 $ 1,569 $ 1,566 $ 1,576 $ 1,566
Balances (in shares) 158,355,000 157,642,000 156,928,000 156,644,000 157,642,000 156,644,000
Share repurchases $ (14)     $ (2)    
Share repurchases (in shares) (1,397,000)     (222,000)    
Common stock issued for exercise of options $ 1 $ 6 $ 1 $ 5    
Common stock issued for exercise of options (in shares) 157,000 633,000 155,000 425,000    
Common stock issued for restricted stock awards $ 0 $ 1 $ 1 $ 0    
Common stock issued for restricted stock awards (in shares) 27,000 47,000 11,000 45,000    
Common stock issued to employee stock purchase plan   $ 1   $ 0    
Common stock issued to employee stock purchase plan (in shares)   33,000   36,000    
Balances $ 1,571 $ 1,584 $ 1,571 $ 1,569 $ 1,571 $ 1,571
Balances (in shares) 157,142,000 158,355,000 157,094,000 156,928,000 157,142,000 157,094,000
Additional Paid-in Capital            
Balances $ 746,606 $ 721,543 $ 678,863 $ 652,467 $ 721,543 $ 652,467
Common stock issued for exercise of options 4,914 12,877 5,074 9,418    
Common stock issued for restricted stock awards 0 0 1 0    
Stock-based compensation expense 12,413 9,981 16,413 14,364    
Common stock issued to employee stock purchase plan   2,093   2,517    
Employee stock purchase plan expense 340 112 333 97    
Balances 764,273 746,606 700,684 678,863 764,273 700,684
Retained Earnings            
Balances 1,327,572 1,309,461 1,162,532 1,122,937 1,309,461 1,122,937
Net earnings 27,465 50,993 50,005 89,555    
Share repurchases (80,028)     (19,560)    
Common stock issued for exercise of options (1,074) (15,460)   (11,428)    
Common stock issued for restricted stock awards   (4,768)   (6,427)    
Cash dividends (12,559) (12,654) (12,561) (12,545)    
Balances 1,261,376 1,327,572 1,199,976 1,162,532 1,261,376 1,199,976
Accumulated Other Comprehensive Income            
Balances (78,016) (66,064) (91,810) (75,200) (66,064) (75,200)
Other comprehensive income (loss) 14,355 (11,952) 16,685 (16,762)    
Reclassification of cumulative translation adjustment for Eminence to non-operating income       152    
Balances $ (63,661) $ (78,016) $ (75,125) (91,810) $ (63,661) (75,125)
Noncontrolling Interest            
Balances       (759)   $ (759)
Net earnings       179    
Reclassification of cumulative translation adjustment for Eminence to non-operating income       (33)    
Elimination of noncontrolling equity interest from sale of Eminence       $ 613